Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 9, 2026, 3:06 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 649–672 of 1,280 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Infection Prophylaxis Clear all

Conditions: HIV Counseling and Testing, HIV Infections
Interventions: HIV educational video; Procedure
Lead sponsor: North Bronx Healthcare Network; Other
Eligibility: 18 Years and older
Enrollment: 408 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2004
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Hemorrhagic Fever With Renal Syndrome
Interventions: Vaccine/device combination for prevention of HFRS; Biological
Lead sponsor: U.S. Army Medical Research and Development Command; Federal
Eligibility: 18 Years to 49 Years
Enrollment: 31 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Silver Spring, Maryland

Conditions: HIV/AIDS
Interventions: Relationship skills session for YMSM partnered-individuals and couples; Behavioral
Lead sponsor: University of Michigan; Other
Eligibility: 15 Years to 24 Years
Enrollment: 318 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Hiv
Interventions: DOT mobile app; Other
Lead sponsor: Environment and Health Group, Inc.; Industry
Eligibility: 18 Years to 35 Years · Male only
Enrollment: 108 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Cambridge, Massachusetts

Conditions: HIV Infections, Crack Cocaine Use, Risky Sexual Behavior
Interventions: Prevention Care Advocate; Behavioral
Lead sponsor: Columbia University; Other
Eligibility: 18 Years and older
Enrollment: 413 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2011
U.S. locations: 2
States / cities: Miami, Florida • Atlanta, Georgia

Conditions: HIV Infections
Interventions: Popular Opinion Leader; Behavioral
Lead sponsor: Centers for Disease Control and Prevention; Federal
Eligibility: 18 Years and older · Male only
Enrollment: 27 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2004 – 2009
U.S. locations: 1
States / cities: New Orleans, Louisiana

Conditions: HIV Infections
Interventions: Affect Management, General Health Promotion; Behavioral
Lead sponsor: Rhode Island Hospital; Other
Eligibility: 12 Years to 14 Years
Enrollment: 420 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2014
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Acute Myelogenous Leukemia, Myelodysplastic Syndrome
Interventions: micafungin, posaconazole; Drug
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 113 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2018
U.S. locations: 1
States / cities: New York, New York

Conditions: HIV/AIDS, Cardiovascular Diseases
Interventions: Not listed
Lead sponsor: Duke University; Other
Eligibility: 40 Years and older
Enrollment: 2,039 participants
Timeline: 2014 – 2020
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Human Immunodeficiency Virus, HIV Infections
Interventions: EnvDNA; Biological
Lead sponsor: St. Jude Children's Research Hospital; Other
Eligibility: 18 Years to 40 Years
Enrollment: 6 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2009
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Mycobacterium Avium-intracellulare Infection, HIV Infections, Pneumococcal Infections
Interventions: Not listed
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years and older
Enrollment: 326 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Ends 2000
U.S. locations: 15
States / cities: San Francisco, California • Denver, Colorado • Washington D.C., District of Columbia + 11 more

Conditions: Neonatal Staphylococcal Sepsis
Interventions: Pagibaximab (formerly BSYX-A110); Drug
Lead sponsor: Biosynexus Incorporated; Industry
Eligibility: 3 Days to 7 Days
Enrollment: 53 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2003
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Surgical Site Infection
Interventions: Order set review and modification with facilitation, Order set review and modification; Behavioral · Other
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 0 Days to 75 Years
Enrollment: 18,267 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 10
States / cities: St. Petersburg, Florida • Boston, Massachusetts • Ann Arbor, Michigan + 7 more

Conditions: Condomless Sex, Human Immunodeficiency Virus (HIV), Sexually Transmitted Infection (STI), Alcohol and Drug Use
Interventions: Face-to-Face Young Women's CoOp (YWC), mHealth Young Women's CoOp (YWC), HIV Counseling and Testing; Behavioral
Lead sponsor: RTI International; Other
Eligibility: 18 Years to 25 Years · Female only
Enrollment: 652 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2020
U.S. locations: 4
States / cities: Durham, North Carolina • Greensboro, North Carolina • High Point, North Carolina + 1 more

Conditions: HIV, Empowerment, HIV Infections
Interventions: Prevention Empowerment Intervention for Young Women; Behavioral
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 16 Years to 24 Years · Female only
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2013
U.S. locations: 3
States / cities: Tampa, Florida • Chicago, Illinois • Baltimore, Maryland

Conditions: CMV Infection, CMV, CMV Viremia, CMV Disease
Interventions: Letermovir, Valganciclovir CMV Prophylaxis; Drug
Lead sponsor: Elisabeth Kincaide; Government
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Acquired Immunodeficiency Syndrome
Interventions: Couples HIV counseling and testing, Women's relationship-focused HIV counseling and testing; Behavioral
Lead sponsor: National Development and Research Institutes, Inc.; Other
Eligibility: 18 Years and older
Enrollment: 780 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2008
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Exposure to Sexually Transmissible Disorder (Event)
Interventions: Intervention, Individual evidence-based STI/HIV prevention intervention; Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 16 Years to 30 Years
Enrollment: 68 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Respiratory Syncytial Virus Infections
Interventions: Suptavumab 30 mg/kg, Placebo Matched to Suptavumab, Suptavumab 30 mg/kg- 1 Dose, Suptavumab 30 mg/kg - 2 Doses; Drug
Lead sponsor: Regeneron Pharmaceuticals; Industry
Eligibility: Up to 6 Months
Enrollment: 1,177 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2017
U.S. locations: 107
States / cities: Birmingham, Alabama • Mobile, Alabama • Little Rock, Arkansas + 104 more

Conditions: HIV Infections, Hiv, Sexually Transmitted Infections (Not HIV or Hepatitis), Sexually Transmitted Diseases, Sexual Behavior, Risk Reduction
Interventions: Para ti, para mi, para nosotros (P3), Waitlist Control Para ti, para mi, para nosotros (P3); Behavioral
Lead sponsor: Florida International University; Other
Eligibility: 18 Years and older · Male only
Enrollment: 148 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Prostate Cancer, Urinary Tract Infection, Clostridium Difficile
Interventions: Ciprofloxacin; Drug
Lead sponsor: University of Rochester; Other
Eligibility: 18 Years and older · Male only
Enrollment: 175 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Rochester, New York

Conditions: HIV Pre-exposure Prophylaxis, HEPATITIS C (HCV), Opioid Use Disorder
Interventions: Telehealth Behavioral Intervention for promoting HIV and HCV care and MOUD among Persons who inject drugs (PWID); Behavioral
Lead sponsor: University of Georgia; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Colbert, Georgia

Conditions: HIV Infection, Sexually Transmitted Infections, Implementation
Interventions: Training Tool for Preventing HIV/AIDS among Teens (PHAT) Life; Behavioral
Lead sponsor: Oregon Research Behavioral Intervention Strategies, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 1
States / cities: Springfield, Oregon

Conditions: STI, Sexually Transmitted Diseases, Pre-exposure Prophylaxis
Interventions: App Intervention; Device
Lead sponsor: Louisiana State University Health Sciences Center in New Orleans; Other
Eligibility: 18 Years to 35 Years · Male only
Enrollment: 71 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 2
States / cities: New Orleans, Louisiana

Search by objective public record fields.

An Effective Alternative to the Standard Referral System for HIV Testing in the Emergency Department During Off Hour Tours: A Randomized Trial

Study to Evaluate the Safety, Tolerability, and Immunogenicity of Hantaan and Puumala Virus DNA Vaccines

We Prevent: A Dyadic Approach to HIV Prevention and Care Among Young Male Couples

Mhealth for PrEP Adherence by Young Adult MSM, Phase 2

Project Hope: Hospital Visit is an Opportunity for Prevention and Engagement With HIV-positive Crack Users

ADAPT-POL New Orleans: Adaptation of Prevention Techniques With Popular Opinion Leader

Affect Management for Early Adolescents

Posaconazole Versus Micafungin for Prophylaxis Against Invasive Fungal Infections During Neutropenia in Patients Undergoing Chemotherapy for Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia or Myelodysplastic Syndrome

Pathways to Cardiovascular Disease Prevention (DCRI Central and Statistical Coordinating Center)

Evaluate Tolerability of a Recombinant DNA HIV-1 Vaccine in Healthy Adults

Effects of MAC Preventive Therapy on Disease-Causing Bacteria in HIV-Infected Patients: A Substudy of CPCRA 048

Safety and Pharmacokinetics Study in VLBW Neonates With BSYX-A110

De-Implementation of Unnecessary Surgical Antibiotic Prophylaxis in Children

NC Young Women's CoOp

Empowerment Intervention for Young Women - Phase I

Letermovir vs Valganciclovir in CMV R+ Kidney Transplant

HIV Prevention Intervention for Couples

Developing a Dyadic Intervention for Sexually Transmitted Infection (STI)/HIV Prevention in Youth

Study to Evaluate the Efficacy and Safety of Suptavumab (REGN2222) for the Prevention of Medically Attended RSV (Respiratory Syncytial Virus) Infection in Preterm Infants

Acceptability, Feasibility, and Preliminary Impact of a Web-based, HIV Prevention Toolkit With Cisgender Male Couples in Lima, Peru

Antibiotic Prophylaxis for Urinary Catheter Removal After Radical Prostatectomy

Trauma-informed, Resilience-based Telehealth Intervention for Improving HIV Prevention and HCV Care for Persons Who Inject Drugs in the Deep South (Pilot Testing: Aim3)

Technology-based Training Tool for PHAT Life

Assessing the Feasibility and Preliminary Impact of a mHealth App on Reducing STI Risk in Black MSM PrEP Users